BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 9492055)

  • 1. Demonstration of a relaxin receptor and relaxin-stimulated tyrosine phosphorylation in human lower uterine segment fibroblasts.
    Palejwala S; Stein D; Wojtczuk A; Weiss G; Goldsmith LT
    Endocrinology; 1998 Mar; 139(3):1208-12. PubMed ID: 9492055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway.
    Palejwala S; Stein DE; Weiss G; Monia BP; Tortoriello D; Goldsmith LT
    Endocrinology; 2001 Aug; 142(8):3405-13. PubMed ID: 11459784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of relaxin on bound cAMP in rat uterus.
    Sanborn BM; Sherwood OD
    Endocr Res Commun; 1981; 8(3):179-92. PubMed ID: 6174316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relaxin signalling in primary cultures of human myometrial cells.
    Heng K; Ivell R; Wagaarachchi P; Anand-Ivell R
    Mol Hum Reprod; 2008 Oct; 14(10):603-11. PubMed ID: 18805799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and cross-linking of 32P-labeled human relaxin to human uterine cells and primary rat atrial cardiomyocytes.
    Osheroff PL; King KL
    Endocrinology; 1995 Oct; 136(10):4377-81. PubMed ID: 7664657
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation of biologically active 32P-labeled human relaxin. Displaceable binding to rat uterus, cervix, and brain.
    Osheroff PL; Ling VT; Vandlen RL; Cronin MJ; Lofgren JA
    J Biol Chem; 1990 Jun; 265(16):9396-401. PubMed ID: 2160976
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterization and effects of oestrogen treatment.
    Tan YY; Wade JD; Tregear GW; Summers RJ
    Br J Pharmacol; 1999 May; 127(1):91-8. PubMed ID: 10369460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H2 relaxin is a biased ligand relative to H3 relaxin at the relaxin family peptide receptor 3 (RXFP3).
    van der Westhuizen ET; Christopoulos A; Sexton PM; Wade JD; Summers RJ
    Mol Pharmacol; 2010 May; 77(5):759-72. PubMed ID: 20159943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relaxin receptors in mice: demonstration of ligand binding in symphyseal tissues and uterine membrane fragments.
    Yang S; Rembiesa B; Büllesbach EE; Schwabe C
    Endocrinology; 1992 Jan; 130(1):179-85. PubMed ID: 1309327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevention of bleomycin-induced pulmonary fibrosis by a novel antifibrotic peptide with relaxin-like activity.
    Pini A; Shemesh R; Samuel CS; Bathgate RA; Zauberman A; Hermesh C; Wool A; Bani D; Rotman G
    J Pharmacol Exp Ther; 2010 Dec; 335(3):589-99. PubMed ID: 20826567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effect of relaxin and progesterone on cyclic adenosine 3',5'-monophosphate levels in the rat uterus.
    Grazi RV; Goldsmith LT; Schmidt CL; Von Hagen S; Weiss G
    Am J Obstet Gynecol; 1988 Dec; 159(6):1402-6. PubMed ID: 2462790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of relaxin receptors in rat isolated atria and uterus by use of synthetic and native relaxin analogues.
    Tan YY; Wade JD; Tregear GW; Summers RJ
    Br J Pharmacol; 1998 Feb; 123(4):762-70. PubMed ID: 9517397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progesterone receptor regulation in uterine cells: stimulation by estrogen, cyclic adenosine 3',5'-monophosphate, and insulin-like growth factor I and suppression by antiestrogens and protein kinase inhibitors.
    Aronica SM; Katzenellenbogen BS
    Endocrinology; 1991 Apr; 128(4):2045-52. PubMed ID: 1706263
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increase in cyclic AMP levels by relaxin in newborn rhesus monkey uterus cell culture.
    Kramer SM; Gibson UE; Fendly BM; Mohler MA; Drolet DW; Johnston PD
    In Vitro Cell Dev Biol; 1990 Jun; 26(6):647-56. PubMed ID: 2162818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RXFP1-inactive relaxin activates human glucocorticoid receptor: further investigations into the relaxin-GR pathway.
    Dschietzig T; Bartsch C; Baumann G; Stangl K
    Regul Pept; 2009 Apr; 154(1-3):77-84. PubMed ID: 19101597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relaxin family peptide receptors RXFP1 and RXFP2 modulate cAMP signaling by distinct mechanisms.
    Halls ML; Bathgate RA; Summers RJ
    Mol Pharmacol; 2006 Jul; 70(1):214-26. PubMed ID: 16569707
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of cyclic AMP in isolated rat uterine tissue slices by porcine relaxin.
    Judson DG; Pay S; Bhoola KD
    J Endocrinol; 1980 Oct; 87(1):153-9. PubMed ID: 6253589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of binding sites with differing affinity and potency for relaxin analogues on LGR7 and LGR8 receptors.
    Halls ML; Bathgate RA; Sudo S; Kumagai J; Bond CP; Summers RJ
    Ann N Y Acad Sci; 2005 May; 1041():17-21. PubMed ID: 15956682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relaxin receptor LGR7 (RXFP1) is regulated by estrogen.
    Maseelall P; Gardner J; Wojtczuk A; Weiss G; Goldsmith LT
    Ann N Y Acad Sci; 2009 Apr; 1160():91-2. PubMed ID: 19416165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tissue-specific effects of relaxin on the reproductive tract of neonatal gilts.
    Yan W; Wiley AA; Bartol FF; Bagnell CA
    Ann N Y Acad Sci; 2005 May; 1041():132-5. PubMed ID: 15956697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.